Biotech
Genova Therapeutics
Pioneering gene-editing therapies to combat rare and chronic diseases.
Seed
Company Story
Genova Therapeutics
Genova Therapeutics is reimagining healthcare through next-generation gene-editing solutions. Their CRISPR-based platform develops targeted therapies for rare and chronic diseases that previously had limited treatment options. With a focus on precision medicine, Genova is working on therapies that drastically reduce time-to-market while ensuring patient safety.
Investment Impact
Investment Impact
Forma VC partnered at Seed, supporting Genova in establishing its R&D infrastructure and navigating regulatory approvals. Forma VC also introduced Genova to top-tier academic collaborators and pharmaceutical partners, helping accelerate its move toward clinical trials.
By the Numbers
0X
0X
Clinical trial pipeline expansion in 18 months
0
0
Clinical trial pipeline expansion in 18 months
$0M
$0M
Raised in follow-on Series A funding
Founder
“Forma VC’s guidance turned our vision into a scalable business. They gave us the resources and network to move from a lab project to a clinical-stage company.”
Ethan Zhao
CTO & Co-Founder